CD8A and infection: In the parental BCN01 trial, a prime/boost vaccine regimen with ChAdV63.HIVconsv and MVA.HIVconsv induced high frequencies of T cells with high in vitro suppressive capacity that markedly shifted the focus of the CD8+ CTL response toward HIVconsv sequences that are subdominant during natural infection (20).